A clinical view of vancomycin in 1990.
作者信息
Siebert W T
机构信息
The Infectious Diseases Section, The University of Texas Health Science Center, and Baylor College of Medicine, Houston, Texas, USA.
出版信息
Tex Heart Inst J. 1990;17(1):5-9.
Abstract
摘要
相似文献
1
A clinical view of vancomycin in 1990.
Tex Heart Inst J. 1990;17(1):5-9.
2
[To discuss the vancomycin-resistant staphylococcus aureus and vancomycin-resistant enterococcus from laboratory view].
Zhonghua Yi Xue Za Zhi. 2006 Apr 18;86(15):1009-10.
3
Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
Int J Clin Pharmacol Ther Toxicol. 1982 Dec;20(12):559-63.
4
Vancomycin peak serum concentration monitoring.
J Intraven Nurs. 1999 Nov-Dec;22(6):336-42.
5
Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
Int J Antimicrob Agents. 2010 Aug;36(2):182-6. doi: 10.1016/j.ijantimicag.2010.03.015. Epub 2010 May 8.
6
[Loading dose of vancomycin: is there a consensus view?].
Ann Fr Anesth Reanim. 2004 Jul;23(7):755. doi: 10.1016/j.annfar.2004.04.006.
7
Cystoid macular edema after cataract surgery with intraocular vancomycin.
Ophthalmology. 1999 Sep;106(9):1660-4. doi: 10.1016/S0161-6420(99)90339-1.
8
Vancomycin use in 2 Ontario tertiary care hospitals: a survey.
Clin Invest Med. 1999 Dec;22(6):256-64.
9
Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Ann Pharmacother. 2011 Jun;45(6):757-63. doi: 10.1345/aph.1P634. Epub 2011 Jun 7.
10
Survival after necrotizing enterocolitis of leukemia treated with oral vancomycin.
Gastroenterology. 1981 Oct;81(4):791-4.
本文引用的文献
1
Antimicrobial susceptibilities of Clostridium difficile.
J Clin Pathol. 1980 Oct;33(10):1002-5. doi: 10.1136/jcp.33.10.1002.
2
Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts: report of three cases.
J Neurosurg. 1981 Oct;55(4):633-6. doi: 10.3171/jns.1981.55.4.0633.
3
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.
Infection. 1982;10(4):205-8. doi: 10.1007/BF01666910.
4
Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.
Antimicrob Agents Chemother. 1981 May;19(5):716-25. doi: 10.1128/AAC.19.5.716.
5
Vancomycin for treatment of bacterial meningitis.
Rev Infect Dis. 1981 Nov-Dec;3 suppl:S289-92.
6
Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.
Ann Intern Med. 1983 Apr;98(4):447-55. doi: 10.7326/0003-4819-98-4-447.
7
Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis.
Ann Intern Med. 1984 Apr;100(4):533-4. doi: 10.7326/0003-4819-100-4-533.
8
Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
Clin Pharmacol Ther. 1983 Nov;34(5):631-7. doi: 10.1038/clpt.1983.225.
9
Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
J Antimicrob Chemother. 1984 Apr;13(4):353-9. doi: 10.1093/jac/13.4.353.
10
Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 1984 Aug;26(2):220-3. doi: 10.1128/AAC.26.2.220.
Zotero 插件